North America Stem Cell Therapy Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 - COVID-19 Impact and Regional Analysis by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, and Other Stem Cell Therapy), Treatment (Allogeneic and Autologous), Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery & Development, and Other Applications), and End User (Hospitals & Specialty Clinics and Academic & Research Institutes)

No. of Pages: 133    |    Report Code: BMIRE00028486    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Stem Cell Therapy Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Stem Cell Therapy Market – By Type

1.3.2        North America Stem Cell Therapy Market – By Treatment

1.3.3        North America Stem Cell Therapy Market – By Application

1.3.4        North America Stem Cell Therapy Market – By End User

1.3.5        North America Stem Cell Therapy Market – By Country

2.           North America Stem Cell Therapy Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Stem Cell Therapy Market– Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Stem Cell Therapy Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Research Activities Related to Stem Cell Therapy for Effective Disease Management

5.1.2        Growing Prevalence of Cancer

5.2         Market Restraints

5.2.1        Availability of Illegal and Unapproved Products, and High Cost of Approved Treatments

5.3         Market Opportunities

5.3.1        Use of Induced Pluripotent Stem Cells in Regenerative Medicines

5.4         Future Trends

5.4.1        Research Activities and Product Innovations

5.5         Impact Analysis

6.           Stem Cell Therapy Market – North America Analysis

6.1         North America Stem Cell Therapy Market Revenue Forecast and Analysis

7.           North America Stem Cell Therapy Market – Revenue and Forecast to 2028 – by Type

7.1         Overview

7.2         North America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)

7.3         Adult Stem Cell Therapy

7.3.1        Overview

7.3.2        Adult Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Hematopoietic Stem Cell Therapy

7.3.3.1          Overview

7.3.3.2          Hematopoietic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Umbilical Cord Stem Cell Therapy

7.3.4.1          Overview

7.3.4.2          Umbilical Cord Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.3.5        Neuronal Stem Cell Therapy

7.3.5.1          Overview

7.3.5.2          Neuronal Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.3.6        Mesenchymal Stem Cell

7.3.6.1          Overview

7.3.6.2          Mesenchymal Stem Cell: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Embryonic Stem Cell Therapy

7.4.1        Overview

7.4.2        Embryonic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Induced Pluripotent Stem Cell Therapy

7.5.1        Overview

7.5.2        Induced Pluripotent Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

7.6         Other Stem Cell Therapy

7.6.1        Overview

7.6.2        Other Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

8.           North America Stem Cell Therapy Market Analysis and Forecasts to 2028 – by Treatment

8.1         Overview

8.2         North America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)

8.3         Allogeneic

8.3.1        Overview

8.3.2        Allogeneic: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Autologous

8.4.1        Overview

8.4.2        Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.           North America Stem Cell Therapy Market Analysis and Forecasts to 2028 – by Application

9.1         Overview

9.2         North America Stem Cell Therapy Market, by Application 2021 & 2028 (%)

9.3         Musculoskeletal

9.3.1        Overview

9.3.2        Musculoskeletal: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4         Dermatology

9.4.1        Overview

9.4.2        Dermatology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Cardiology

9.5.1        Overview

9.5.2        Cardiology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Drug Discovery and Development

9.6.1        Overview

9.6.2        Drug Discovery and Development: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

9.7         Other Applications

9.7.1        Overview

9.7.2        Other Applications: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10.        North America Stem Cell Therapy Market – Revenue and Forecast to 2028 – by End User

10.1      Overview

10.2      North America Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)

10.3      Academic & Research Institutes

10.3.1     Overview

10.3.2     Academic & Research Institutes: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

10.4      Hospitals & Specialty Clinics

10.4.1     Overview

10.4.2     Hospitals & Specialty Clinics: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.        North America Stem Cell Therapy Market – Revenue and Forecast to 2028 – Country Analysis

11.1      North America: Stem Cell Therapy Market

11.1.1     Overview

11.1.1.1       US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.1.3       US: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)

11.1.1.1.3.1     US: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)

11.1.1.1.4       US: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)

11.1.1.1.5       US: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)

11.1.1.1.6       US: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)

11.1.1.2       Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.2.3       Canada: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)

11.1.1.2.3.1     Canada: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)

11.1.1.2.4       Canada: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)

11.1.1.2.5       Canada: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)

11.1.1.2.6       Canada: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)

11.1.1.3       Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

11.1.1.3.3       Mexico: Stem Cell Therapy Market, by Type, 2019–2028 (US$ Million)

11.1.1.3.3.1     Mexico: Stem Cell Therapy Market, by Adult Stem Cell Therapy, 2019–2028 (US$ Million)

11.1.1.3.4       Mexico: Stem Cell Therapy Market, by Treatment, 2019–2028 (US$ Million)

11.1.1.3.5       Mexico: Stem Cell Therapy Market, by Application, 2019–2028 (US$ Million)

11.1.1.3.6       Mexico: Stem Cell Therapy Market, by End User, 2019–2028 (US$ Million)

12.        Stem Cell Therapy Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies in the Stem Cell Therapy Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      MEDIPOST

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      RichSource

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      BioTime, Inc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Mesoblast Limited

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      U.S. Stem Cell, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      TiGenix NV

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      AlloSource

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      NuVasive Inc

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             Cost Expenditure of Stem Cell Injection

Table 2.             US Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 3.             US Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)

Table 4.             US Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 5.             US Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 6.             US Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Canada Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Canada Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Canada Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Canada Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Canada Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Mexico Stem Cell Therapy Market, by Type – Revenue and Forecast to 2028 (US$ Million)

Table 13.          Mexico Stem Cell Therapy Market, by Adult Stem Cell Therapy – Revenue and Forecast to 2028 (US$ Million)

Table 14.          Mexico Stem Cell Therapy Market, by Treatment – Revenue and Forecast to 2028 (US$ Million)

Table 15.          Mexico Stem Cell Therapy Market, by Application – Revenue and Forecast to 2028 (US$ Million)

Table 16.          Mexico Stem Cell Therapy Market, by End User – Revenue and Forecast to 2028 (US$ Million)

Table 17.          Organic Developments in the Stem Cell Therapy Market

Table 18.          Inorganic Developments in the Stem Cell Therapy Market

Table 19.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           North America Stem Cell Therapy Market Segmentation

Figure 2.           North America Stem Cell Therapy Segmentation, By Country

Figure 3.           North America Stem Cell Therapy Market Overview

Figure 4.           Adult Stem Cell Therapy Segment Held Largest Share of Type Segment in North America Stem Cell Therapy Market

Figure 5.           US Is Expected to Show Remarkable Growth During the Forecast Period

Figure 7.           North America: PEST Analysis

Figure 8.           Experts Opinion

Figure 9.           North America Stem Cell Therapy Market Impact Analysis of Drivers and Restraints

Figure 10.        North America Stem Cell Therapy Market – Revenue Forecast and Analysis – 2020- 2028

Figure 11.        North America Stem Cell Therapy Market Revenue Share, by Type 2021 & 2028 (%)

Figure 12.        Adult Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Hematopoietic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Umbilical Cord Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Neuronal Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Mesenchymal Stem Cell: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Embryonic Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Induced Pluripotent Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Other Stem Cell Therapy: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        North America Stem Cell Therapy Market, by Treatment 2021 & 2028 (%)

Figure 21.        Allogeneic: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 22.        Autologous: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        North America Stem Cell Therapy Market, by Application 2021 & 2028 (%)

Figure 24.        Musculoskeletal: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 25.        Dermatology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        Cardiology: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Drug Discovery and Development: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Other Applications: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        North America Stem Cell Therapy Market Revenue Share, by End User 2021 & 2028 (%)

Figure 30.        Academic & Research Institutes: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 31.        Hospitals & Specialty Clinics: North America Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 32.        North America: Stem Cell Therapy Market, by Key Country – Revenue (2021) (US$ Million)

Figure 33.        North America: Stem Cell Therapy Market, by Country, 2021 & 2028 (%)

Figure 34.        US: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 35.        Canada: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 36.        Mexico: Stem Cell Therapy Market – Revenue and Forecast to 2028 (US$ Million)

Figure 37.        Growth Strategies in the Stem Cell Therapy Market (%)

The List of Companies - North America Stem Cell Therapy Market

  1. MEDIPOST
  2. RichSource
  3. BioTime, Inc.
  4. Mesoblast Limited
  5. U.S. Stem Cell, Inc.
  6. TiGenix NV
  7. AlloSource
  8. NuVasive Inc